Identification of Inhibitors against Metastasis Protein “Survivin:” In silico Discovery Using Virtual Screening and Molecular Docking Studies
Swechha Mishra1, Sangeeta Singh1★★ Corresponding author
- 1Department of Applied Sciences, Indian Institute of Information Technology, Allahabad, Uttar Pradesh, India.
CORRESPONDENCE
Sangeeta Singh
Department of Applied Sciences, Indian Institute of Information Technology, Allahabad, Uttar Pradesh, India.
Received: 06-05-2017; Revised: 03-06-2017.
Volume 13, Issue 52s · pp. S742–S748 · PUBLISHED 31 January 2018 · DOI: 10.4103/pm.pm_178_17
View on Pharmacogn. Mag. original site ↗
ABSTRACT
Background: In experimental therapy of cancer, survivin is considered to be one of the well‑established targets. Studies have found that it is overexpression in most of the human tumors, but it is rarely found in normal tissues. It is having varied structural and functional role. It controls cell division and cellular stress response and also regulates metastasis and migration of cancerous cells. It has also been recognized as a biomarker which makes it unconventional drug target. In spite of being one of the centrally active components in metastasis and invasion, their clinical use is minimal. To increase the therapeutic efficiency of cancer and its various stages, it is important to survey novel reagents targeting the pathways and mechanism involving survivin. Objective: The aim of this study was to identify novel survivin inhibitor candidates using in silico screening. Materials and Methods: In this course of work, virtual screening on a dataset of natural compounds retrieved from ZINC and other libraries were performed. Comparative analysis of the protein was done by studying the binding affinity of inhibitors that are already available. The best interacting complex was set for molecular dynamics simulation for 25 ns to validate the stability of system. These molecules were checked for their toxicity and absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties using OSIRIS and pre‑ADMET tools. Results: We discovered ten such candidates with better binding efficiency with survivin in comparison to marketed chemical against the same. Furthermore, these inhibitor candidates did not induce cell toxicity. Binding affinity of reference molecules was varied from −6.8 to −8.5 kcal/mol while that of top scoring compound ZINC00689728 is −9.3 kcal/mol binding energy. Good placement and strong bond formation of selected molecule was observed during course of work. It is also having permissible ADMET property. Conclusion: Considering all the parameters, the screened molecule can be considered as a potential lead compound for designing new drug against survivin. Further investigation and testing will be required to make it to the final stage.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Mishra, S., & Singh, S. (2018). Identification of Inhibitors against Metastasis Protein “Survivin:” In silico Discovery Using Virtual Screening and Molecular Docking Studies. Pharmacognosy Magazine, 13(52s), S742–S748. https://doi.org/10.4103/pm.pm_178_17